These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 13064629)

  • 1. A comparative study of the virulence and protective potency against tuberculous infection of vole bacillus, low-virulent human tubercle bacillus Imamura's strain, and BCG.
    TOSHIMA M
    Sci Rep Res Inst Tohoku Univ Med; 1952 Dec; 4(2):135-49. PubMed ID: 13064629
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunization with the vole bacillus; the protective value of the vole bacillus (Wells) as compared with BCG against tuberculous infection.
    BIRKHAUG K
    Am Rev Tuberc; 1946 May; 53():411-26. PubMed ID: 20984406
    [No Abstract]   [Full Text] [Related]  

  • 3. The persistence of resistance following the disappearance of hypersensitivity in guinea-pigs after vaccination with vole bacillus and BCG.
    WELLS AQ; WYLIE JA
    Br J Exp Pathol; 1952 Aug; 33(4):405-14. PubMed ID: 14954113
    [No Abstract]   [Full Text] [Related]  

  • 4. Practical experience with BCG and the Vole bacillus in Renfrew-shire.
    FREW HW
    Tubercle; 1954 Nov; 35(11):277-87. PubMed ID: 13217030
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of vaccination with vole bacillus and B.C.G. vaccines.
    FREW HW; DAVIDSON JR; REID JT
    Br Med J; 1955 Jan; 1(4906):133-6. PubMed ID: 13219360
    [No Abstract]   [Full Text] [Related]  

  • 6. The hemagglutination reaction to BCG and vole bacillus vaccinations.
    HAWIRKO RZ
    Can J Microbiol; 1954 Aug; 1(1):79-84. PubMed ID: 14352042
    [No Abstract]   [Full Text] [Related]  

  • 7. B.C.G. and vole bacillus vaccines in the prevention of tuberculosis in adolescents.
    Br Med J; 1959 Sep; 2(5149):379-96. PubMed ID: 13856755
    [No Abstract]   [Full Text] [Related]  

  • 8. Vole bacillus vaccination in guinea pigs: comparison of immunization produced by virulent and attenuated strains of vole bacillus.
    SMITH N
    Tubercle; 1962 Jun; 43():161-5. PubMed ID: 13914367
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the potency test of BCG vaccine; studies on the inoculation of tubercle bacilli (or BCG) into the ocular anterior-chamber of rabbits. I. The inoculation of bacilli into the ocular anterior-chamber of rabbits for a virulence test of tubercle bacilli or a potency test of BCG vaccine.
    SAKAKI K
    Sci Rep Res Inst Tohoku Univ Med; 1956 Jul; 7(1):75-96. PubMed ID: 13432807
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple puncture with B.C.G. and vole bacillus vaccine; a comparative trial.
    HALL IM; WYLIE JA
    Lancet; 1952 Sep; 2(6735):608-10. PubMed ID: 12981924
    [No Abstract]   [Full Text] [Related]  

  • 11. B.C.G. AND vole bacillus vaccines in the prevention of tuberculosis in adolescents; first (progress) report to the Medical Research Council by their Tuberculosis Vaccines Clinical Trials Committee.
    Br Med J; 1956 Feb; 1(4964):413-27. PubMed ID: 13284343
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the potency test of BCG vaccine; studies on the inoculation of tubercle bacilli (or BCG) into the ocular anterior-chamber of rabbits. II. Determination of the protective effect of BCG vaccines by the challenge with virulent human tubercle bacilli into the ocular anterior-chamber of the immunized rabbits.
    SAKAKI K
    Sci Rep Res Inst Tohoku Univ Med; 1956 Jul; 7(1):97-113. PubMed ID: 13432808
    [No Abstract]   [Full Text] [Related]  

  • 13. VACCINATION AGAINST TUBERCULOSIS WITH KILLED TUBERCLE BACILLI.
    SWEDBERG B
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:67-76. PubMed ID: 14164138
    [No Abstract]   [Full Text] [Related]  

  • 14. [COMPARATIVE TUBERCULIN REACTIONS TO THE A OR A + B PROTEINS AND TO THE PPD TUBERCULIN PREPARED FROM THE MOREAU STRAIN OF TUBERCLE BACILLI IN TUBERCULOUS AND BCG-VACCINATED CHILDREN].
    KRZYSZKOWSKA A; ZIOLECKA I; RZUCIDLO L; GOLASZEWSKA W; STUDNICKA K; TYSZKA K; WERYS R
    Gruzlica (1926); 1963 Sep; 31():945-54. PubMed ID: 14121093
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccination with the vole bacillus (Wells); protective value of percutaneous and intracutaneous vaccination; observations on multiple puncture vaccination on man.
    BIRKHAUG K
    Am Rev Tuberc; 1946 Jul; 54():41-50. PubMed ID: 20995858
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative antigenic potency of killed irradiated tubercle bacilli and living BCG vaccine.
    BIRKHAUG K; DARRICARRERE R
    Proc Soc Exp Biol Med; 1952 Mar; 79(3):387-90. PubMed ID: 14920438
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TUBERCLE BACILLARY EXTRACTS IMMUNOGENIC FOR MICE. 6. COMPARATIVE IMMUNOGENICITY OF TRYPSIN EXTRACT OF TUBERCLE BACILLI IN MICE AND GUINEA PIGS.
    CROWLE AJ; TERAMURA F
    Tubercle; 1964 Mar; 45():40-6. PubMed ID: 14129198
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.
    Henao-Tamayo M; Obregón-Henao A; Creissen E; Shanley C; Orme I; Ordway DJ
    Clin Vaccine Immunol; 2015 Jan; 22(1):91-8. PubMed ID: 25392011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.